WebCullinan Oncology is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's … WebApr 13, 2024 · Institutional & Insider Ownership 48.2% of TScan Therapeutics shares are owned by institutional investors. Comparatively, 46.6% of shares of all “Biological products, except diagnostic” companies...
Overview Of Value Stocks In The Healthcare Sector
WebMar 6, 2024 · Cullinan Oncology And Investors Investor Overview Our diverse pipeline combines a unique portfolio model with innovative sourcing techniques and drug … WebApr 6, 2024 · A high-level overview of Cullinan Oncology, Inc. (CGEM) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … alitalia cane in cabina
CGEM Cullinan Oncology Inc. Stock Price & News - WSJ
WebCullinan Oncology (NASDAQ: CGEM) is owned by 95.72% institutional shareholders, 99.45% Cullinan Oncology insiders, and 0.00% retail investors. Ansbert Gadicke is the … WebApr 6, 2024 · Cullinan Oncology currently has issued a total of 39,330,000 shares. Some of Cullinan Oncology's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open … WebView the latest Cullinan Oncology Inc. (CGEM) stock price, news, historical charts, analyst ratings and financial information from WSJ. CGEM Cullinan Oncology Inc. Stock Price … alitalia brasil telefone contato